Monday, November 3, 2003: 3:00 PM-4:15 PM | |||
Lipodystrophic Symptomatology, Medication Adherence, Depression, CAM Therapies, and Health-Related Quality of Life in Persons with HIV Disease | |||
| Learning Objective #1: Identify the relationships among lipodystrophic symptomatology, the use of CAM therapies, medication adherence, depression, and health-related quality of life in persons with HIV/AIDS | |||
| Learning Objective #2: Evaluate the trajectory from illness representation (symptom identification) to outcomes appraisal (quality of life) through symptom self-care management strategies in persons with HIV disease | |||
| Since the advent of HAART, persons with HIV/AIDS who receive treatment generally are living longer. However, with increased longevity, individuals with HIV/AIDS are reporting increased medication- and disease-related symptomatology. One of the pervasive symptoms is lipodystrophy, which is characterized by potentially life-altering sequelae, including metabolic and morphologic deviations. While the primary goal of HIV care is to delay disease progression through the use of antiretroviral therapies, healthcare providers are challenged to assist HIV-infected persons in identifying strategies to improve health status, suppress disease and treatment-related symptomatology, and enhance health-related quality of life. This symposium focuses on issues related to lipodystrophic symptomatology, medication adherence, self-care measures (e.g., complementary and alternative therapies), depression, and health-related quality of life in persons with HIV/AIDS. The consensus in the symptom management literature is that the patient is the ‘gold standard’ for understanding the symptom experience. Hence, the importance of capturing HIV symptoms from the client’s perspective is imperative. The first paper addresses correlates of lipodystrophic manifestations, the complementary/alternative therapies used by persons with HIV disease to self manage their symptoms, and the perceived effectiveness of these therapies. Self-report of adherence is widely accepted in symptom identification. The second paper reports on the relationship between lipodystrophy-associated morphologic/metabolic changes and medication adherence in persons infected with HIV/AIDS. A frequently reported predictor of quality of life is depression. The third paper presents the relationship between lipodystrophy-associated morphologic/metabolic changes and depression in HIV-infected persons. And the last paper presents data analyzing the relationship between lipodystrophy-associated symptoms and health-related quality of life in those infected with HIV/AIDS. | |||
| Organizer: | Kenn M. Kirksey, RN, PhD, APRN, BC | ||
| Correlates of Lipodystrophic Symptoms and Complementary Therapies Kenn M. Kirksey, RN, PhD, APRN, BC, Inge B. Corless, RN, PhD, FAAN, Patrice Kenneally Nicholas, RN, DNSc, MPH, ANP, Jeanne Kemppainen, RN, PhD, CNS, Margaret E. Mueller, RN, MSN | |||
| Relationship between lipodystrophy-associated morphologic/metabolic changes and depression in persons infected with HIV/AIDS Jeanne Kemppainen, RN, PhD, CNS, Kenn M. Kirksey, RN, PhD, APRN, BC, Patrice Kenneally Nicholas, RN, DNSc, MPH, ANP, Inge B. Corless, RN, PhD, FAAN, Margaret E. Mueller, RN, MSN | |||
| Relationship between lipodystrophy-associated morphologic/metabolic changes and health-related quality of life in persons infected with HIV/AIDS Patrice Kenneally Nicholas, RN, DNSc, MPH, ANP, Kenn M. Kirksey, RN, PhD, APRN, BC, Inge B. Corless, RN, PhD, FAAN, Jeanne Kemppainen, RN, PhD, CNS, Margaret E. Mueller, RN, MSN | |||
| Relationship between lipodystrophy-associated symptoms and medication adherence in persons infected with HIV/AIDS Inge B. Corless, RN, PhD, FAAN, Kenn M. Kirksey, RN, PhD, APRN, BC, Patrice Kenneally Nicholas, RN, DNSc, MPH, ANP, Jeanne Kemppainen, RN, PhD, CNS, Margaret E. Mueller, RN, MSN | |||
37th Biennial Convention - Scientific Session
Sigma Theta Tau International